NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Sagility Ltd FY26 Results: Total Assets Up 14%, Non-Current Debt Reduced to Zero
Sagility Limited reported a strong balance sheet for the fiscal year ended March 31, 2026, with total assets growing 14% to ₹126,010.78 million. A significant highlight is the complete repayment of non-current borrowings, which fell from ₹5,670.42 million to nil. Total equity also saw a healthy increase to ₹96,590.97 million from ₹83,360.54 million. However, trade receivables spiked by 45% to ₹18,390.31 million, which may indicate a longer collection cycle that investors should monitor.
முக்கிய அம்சங்கள்
Total assets increased by 14% year-on-year to reach ₹126,010.78 million.Non-current borrowings were fully liquidated, down from ₹5,670.42 million in March 2025.Trade receivables rose significantly to ₹18,390.31 million from ₹12,667.61 million.Cash, bank balances, and current investments combined exceeded ₹9,000 million.Goodwill remains a substantial portion of the balance sheet at ₹64,051.49 million following recent acquisitions.
👀 கவனிக்க வேண்டியவை
Investors should take confidence in the company's transition to a debt-free status on a non-current basis. However, keep a close watch on the rising trade receivables and the high goodwill-to-assets ratio for potential future impairment risks.
Sagility Reports Strong FY26 Performance with 39.5% Growth in Adjusted PAT to ₹11,306 Million
Sagility Limited delivered a robust performance for FY26, with annual revenue growing 29.1% to ₹71,929 million and Adjusted PAT surging 39.5% to ₹11,306 million. The company successfully reduced its net debt from ₹10,433 million to ₹1,962 million, significantly improving its leverage ratio to 0.09x. Growth was driven by 17 new client additions and expansion within existing accounts, particularly in the healthcare payer segment which accounts for 89.7% of revenue. The company also announced a final dividend of ₹0.1 per share.
முக்கிய அம்சங்கள்
FY26 Revenue grew 29.1% YoY to ₹71,929 million, with 25.8% organic growth excluding Broadpath.Adjusted PAT for the full year increased by 39.5% to ₹11,306 million, with Adjusted EPS rising to ₹2.42 from ₹1.76.Net Debt drastically reduced to ₹1,962 million from ₹10,433 million in the previous year.Onboarded 17 new clients in FY26, bringing the total active client groups to 82.Adjusted EBITDA margin remained healthy at 25.3% for the full year FY26.
👀 கவனிக்க வேண்டியவை
Investors should take note of the significant debt reduction and strong organic growth, which signal high operational efficiency. The company's focus on AI-led healthcare operations and a growing client base in the US market makes it a strong contender in the healthcare BPO space.
Sagility Limited Receives ₹100 Crore Income Tax Demand for AY 2023-24
Sagility Limited has received a final income tax assessment order for the Assessment Year 2023-24, involving a total demand of ₹100.00 crore including interest. The demand is primarily driven by transfer pricing adjustments of ₹189.50 crore made by the Income Tax Department. The company intends to contest the order by filing an appeal with the Commissioner of Income Tax (Appeals) and a rectification application to correct apparent mistakes. Management currently maintains that the order will not have a material impact on the company's financial or operational activities.
முக்கிய அம்சங்கள்
Total income tax demand of ₹100,00,36,187 (including interest) raised for AY 2023-24.Transfer pricing adjustments of ₹189,50,16,208 were made to the company's returned income.Company is in the process of filing an appeal before the Commissioner of Income Tax (Appeals).A rectification application is being filed to correct mistakes in the assessment order which could lead to a material reduction in demand.
👀 கவனிக்க வேண்டியவை
Investors should monitor the progress of the tax appeal and rectification application, as a ₹100 crore demand is significant. While the company is contesting it, any unfavorable final ruling could impact future cash flows.
Sagility Limited Highlights 24-25% EBITDA Margins and AI Strategy at Investor Day
Sagility Limited showcased its long-term growth trajectory at its Investor Day, reporting consistent double-digit revenue growth and EBITDA margins of 24-25% over the last five years. The company maintains deep relationships with 7 of the top 10 US healthcare payers, with its top five clients averaging an 18-year tenure. Management emphasized that rising Medical Loss Ratios (MLR) in the US, now exceeding 90% for many payers, is creating significant demand for Sagility's cost-optimization and AI-driven operational services. The company is aggressively integrating Agentic AI to enhance efficiency and address margin compression faced by its clients.
முக்கிய அம்சங்கள்
Maintained consistent EBITDA margins in the 24-25% range with double-digit growth over five years.Strong client stickiness with an 18-year average tenure for the top five clients and presence in 7 of the top 10 US payers.Payer segment dominates revenue at 87-88%, while the provider segment accounts for the remaining 12-13%.Strategic focus on AI-led transformation to mitigate US healthcare challenges like rising utilization and funding cuts.Positioned as a leader in 'Intelligent Payer Operations' by industry analysts like Everest and ISG.
👀 கவனிக்க வேண்டியவை
Investors should view Sagility as a stable play on the US healthcare outsourcing market, benefiting from structural cost-pressures in the US that drive demand for their services. Monitor the successful implementation of AI tools as a primary driver for future margin expansion and competitive differentiation.
Sagility Reports 14.9% Revenue Growth in FY25; 9M FY26 EBITDA Margin at 25.5%
Sagility Limited reported a robust financial performance with FY25 revenue reaching $658.3 million, marking a 14.9% year-on-year growth. For the nine months ending December 2025 (9M FY26), the company achieved an adjusted EBITDA margin of 25.5% and an adjusted PAT margin of 15.9%. Despite US healthcare headwinds like rising Medical Loss Ratios (MLRs) for major payers, Sagility is benefiting from increased outsourcing demand as clients seek cost-containment. The company currently serves 7 of the top 10 US payers and maintains a global workforce of over 40,000 associates.
முக்கிய அம்சங்கள்
FY25 revenue grew to $658.3 million from $572.9 million in FY24, representing a 14.9% YoY increase.9M FY26 revenue reached $591.8 million compared to $476.5 million in the previous year's corresponding period.Maintained strong profitability with a 25.5% Adjusted EBITDA margin and 15.9% Adjusted PAT margin for 9M FY26.Client base includes 80+ healthcare organizations, including 7 of the top 10 US payers and 3 of the top 6 PBMs.Operational efficiency is driven by a 90.6% offshore and nearshore delivery model across 35 delivery centers.
👀 கவனிக்க வேண்டியவை
Investors should view Sagility as a resilient play in the US healthcare BPO space, as rising cost pressures on US payers typically drive higher outsourcing volumes. Monitor the company's ability to sustain 25%+ EBITDA margins while integrating GenAI tools into their clinical and administrative workflows.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Sagility Limited Appoints Genpact Veteran Srinivas Mattapalli as Group CFO
Sagility Limited has appointed Mr. Srinivas Rathnam Mattapalli as its new Group Chief Financial Officer and Key Managerial Personnel, effective February 14, 2026. Mr. Mattapalli is an industry veteran with over 30 years of experience, notably serving as Senior Vice President at Genpact (NYSE: G). His expertise includes managing P&L growth, commercial strategy, and digital transformation for global organizations. This leadership change aims to leverage his extensive background in finance and international business to drive the company's future-ready finance ecosystem.
முக்கிய அம்சங்கள்
Mr. Srinivas Rathnam Mattapalli appointed as Group CFO effective February 14, 2026Brings over 30 years of experience in finance leadership and business transformationFormer Senior Vice President at Genpact, overseeing the Hi-Tech and Manufacturing verticalAlumnus of IIM Bangalore and a qualified ICWA professionalPrevious experience includes leadership roles at Hindustan Coca-Cola and Colgate-Palmolive
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development as the company brings in a highly experienced leader from a global peer like Genpact. No immediate action is required, but the market will watch for any strategic financial shifts once he takes office in 2026.
Sagility Limited delivered an exceptional Q3 FY26 with revenue rising 35.7% YoY to ₹19,712 million, supported by a 29.1% constant currency growth. Adjusted EBITDA grew 24.2% to ₹5,125 million, maintaining a strong 26% margin, while 9M FY26 Adjusted PAT saw a significant 44.3% YoY increase to ₹8,236 million. The company is benefiting from the BroadPath acquisition and a strong Medicare Advantage enrollment season, leading to an upward revision in revenue guidance. Management highlighted that exposure to the expiring ACA subsidies is negligible, mitigating regulatory risk.
முக்கிய அம்சங்கள்
Consolidated Q3 revenue reached ₹19,712 million with organic growth at 19.9% in INR terms.Adjusted PAT for 9M FY26 rose 44.3% YoY to ₹8,236 million due to operational efficiency and lower debt.Won $30.5 million in ACV during Q3, including a top 10 health insurance company and a regional plan.Seasonal revenue contribution from Open Enrollment increased to 5.5% for FY26 compared to historical 3%.Active client base expanded to 81, with 7 of 12 new FY26 logos coming from the mid-market segment.
👀 கவனிக்க வேண்டியவை
Sagility's strong organic growth and successful integration of BroadPath make it a compelling play in the US healthcare outsourcing space. Investors should maintain a positive outlook given the guidance upgrade and the company's ability to navigate US regulatory shifts effectively.
Sagility Q3 FY26 Revenue Surges 35.7% YoY to ₹19,712 Million; Adj. PAT Up 23%
Sagility Limited reported a robust Q3 FY26 with consolidated revenue growing 35.7% YoY to ₹19,712 million, supported by a 29.1% growth in constant currency terms. Adjusted EBITDA for the quarter rose 24.2% YoY to ₹5,125 million with a healthy margin of 26.0%. The company's Adjusted PAT for the nine-month period (9M FY26) showed a significant jump of 44.3% YoY, reaching ₹8,236 million. Notably, the company is successfully diversifying its revenue stream, with the top 10 clients' contribution decreasing from 90.5% in FY25 to 84.6% in the current trailing twelve months.
முக்கிய அம்சங்கள்
Q3 Revenue at ₹19,712 million, up 35.7% YoY (29.1% in constant currency).Adjusted PAT for Q3 grew 23.0% YoY to ₹3,229 million with a 16.4% margin.9M FY26 Adjusted PAT increased by 44.3% YoY to ₹8,236 million.Active client groups increased to 81 from 75 in FY25, reducing top-10 client concentration to 84.6%.Employee headcount reached 48,522 across 35 delivery centers in 5 countries.
👀 கவனிக்க வேண்டியவை
Investors should take note of the strong organic growth and successful integration of acquisitions like BroadPath which are driving top-line momentum. The improving client diversification and consistent margins make it a strong play in the U.S. healthcare outsourcing space.
Sagility Limited Receives Credit Rating Upgrade and Subsequent Withdrawal by ICRA
Sagility Limited has announced that ICRA Limited upgraded the credit ratings for its long-term and short-term fund-based bank facilities. Following the upgrade, the ratings were withdrawn at the company's request, supported by a No-Objection Certificate (NOC) from the lender. This sequence indicates an improved credit profile prior to the administrative removal of the rating from public tracking. The withdrawal is in accordance with ICRA's established policy and SEBI regulatory requirements.
முக்கிய அம்சங்கள்
ICRA Limited upgraded the credit ratings for long-term and short-term fund-based bank facilities.Ratings were subsequently withdrawn at the company's request following a No-Objection Certificate from the lender.The disclosure was made under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.The upgrade reflects a strengthening of the company's financial position and creditworthiness.
👀 கவனிக்க வேண்டியவை
Investors should view the rating upgrade as a positive sign of financial health. The withdrawal is likely administrative, but shareholders should monitor for any future changes in the company's debt structure or financing costs.
Sagility Limited Assigned CRISIL A/Stable and A1 Ratings for Rs 300 Crore Bank Facilities
CRISIL Ratings has assigned investment-grade ratings to Sagility Limited's bank loan facilities totaling Rs 300 crore. The company received a long-term rating of 'CRISIL A/Stable' and a short-term rating of 'CRISIL A1'. These ratings indicate a stable outlook and a strong degree of safety regarding the timely servicing of financial obligations. This formal credit assessment provides a benchmark for the company's creditworthiness in the healthcare services sector.
முக்கிய அம்சங்கள்
CRISIL assigned a long-term rating of 'CRISIL A/Stable' for bank facilities.A short-term rating of 'CRISIL A1' was assigned to the company.The total bank loan facilities covered under these ratings amount to Rs 300 crore.The 'Stable' outlook reflects expectations of maintained credit strength over the medium term.
👀 கவனிக்க வேண்டியவை
Investors should take this as a positive sign of the company's financial discipline and creditworthiness. No immediate action is required, but the rating provides a baseline for monitoring future financial health.
Sagility Limited has completed a partial redemption of 1,105 unsecured, unlisted Non-Convertible Debentures (NCDs) on January 02, 2026. The total principal amount repaid to the debenture holder, Sagility B.V., amounts to ₹110.50 crore. Additionally, the company cleared interest obligations of approximately ₹2.13 crore for the period from October 2025 to January 2026 at an 8% annual rate. This redemption follows the shareholder approval previously obtained in March 2025.
முக்கிய அம்சங்கள்
Redeemed 1,105 unsecured, unlisted NCDs with a face value of ₹10,00,000 eachTotal principal amount of ₹110.50 crore paid to debenture holder Sagility B.V.Interest payment of ₹2.13 crore made for the period Oct 1, 2025, to Jan 1, 2026Redemption executed at an interest rate of 8% per annumAction follows shareholder approval via postal ballot dated March 21, 2025
👀 கவனிக்க வேண்டியவை
This deleveraging move is a positive indicator of the company's cash flow strength and commitment to reducing interest-bearing debt. Investors should monitor the impact of reduced interest costs on the company's net profit margins in upcoming quarters.
Sagility Limited Q2 FY25 PAT Surges 69% QoQ to ₹2,508 Million
Sagility Limited has submitted its machine-readable financial results for the quarter and half-year ended September 30, 2025. The company reported a consolidated revenue of ₹16,584.99 million for Q2 FY25, marking a 7.7% growth over the previous quarter. Net profit for the quarter saw a substantial jump to ₹2,508.26 million compared to ₹1,485.59 million in Q1 FY25. The results reflect strong operational performance and sequential growth in the healthcare services segment.
முக்கிய அம்சங்கள்
Consolidated revenue from operations grew 7.7% QoQ to ₹16,584.99 million in Q2 FY25.Net profit (PAT) for the quarter stood at ₹2,508.26 million, a 68.8% increase over Q1 FY25.Half-year (H1 FY25) revenue reached ₹31,974.41 million with a total PAT of ₹3,993.85 million.Basic and Diluted EPS improved to ₹0.53 for the quarter from ₹0.32 in the preceding quarter.Total assets as of September 30, 2025, increased to ₹1,15,272.97 million, with equity at ₹88,944.57 million.
👀 கவனிக்க வேண்டியவை
Investors should note the strong sequential growth in profitability and revenue, which indicates positive business momentum. The stock remains a key play in the healthcare BPM space, though investors should monitor the high goodwill component on the balance sheet.
SAGILITY receives Income Tax order for AY 2022-23 with demand of ₹351.3 million
Sagility Limited has received an order from the Income Tax Department for the assessment year 2022-23, resulting in a tax demand of ₹351.3 million (including interest). The Income Tax Authority made transfer pricing and other adjustments in the returned income of AY 2022-23 to the extent of ₹1,079.9 million. The company believes the demand is not maintainable and plans to appeal before the Income Tax Appellate Tribunal. Sagility states that the assessment order has no material impact on the financials, operations, or other activities of the company.
முக்கிய அம்சங்கள்
Tax demand of ₹351.3 million (including interest) for AY 2022-23Income Tax Authority made adjustments of ₹1,079.9 millionOrder under section 143(3) read with section 144C(13) read with section 144B of the Income Tax Act,1961Company plans to appeal the order
👀 கவனிக்க வேண்டியவை
Investors should monitor the progress of Sagility's appeal against the income tax order. While the company believes the demand is not maintainable, any adverse outcome could potentially affect future earnings.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
